Molecular Biomedicine : Impact Factor & More
eISSN: 2662-8651
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Molecular Biomedicine Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Springer |
| Language | English |
| Publication Time | 10 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Sichuan International Medical Exchange & Promotion Association |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 10 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Molecular Biomedicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Molecular Biomedicine
Organoid technology in cancer research.
- 30 Jun 2026
- Molecular biomedicine
Prolactin-Releasing Hormone Receptor (PRLHR) enhances radiosensitivity and exacerbates DNA damage in glioblastoma post-irradiation by inhibiting Y-box-binding protein-1 (YBX1) nuclear translocation: a novel perspective on precision radiotherapy.
- 29 Jun 2026
- Molecular biomedicine
Gut microbiota and aging: current understanding and future perspectives.
- 25 Jun 2026
- Molecular biomedicine
Prostatic fibroblast reprogramming by Interleukin-30 activates prostate cancer metastasis programs.
- 24 Jun 2026
- Molecular biomedicine
MET-mediated phosphorylation of YANK2 at Y282 inhibits NEDD4L-dependent SUMOylation and degradation, promoting chemoresistance in glioblastoma.
- 24 Jun 2026
- Molecular biomedicine
Death-associated protein kinase 2 (DAPK2) propagates endoplasmic reticulum stress in macrophages to worsen sepsis through HSPA5-IRE1α axis.
- 23 Jun 2026
- Molecular biomedicine
Organoid technology in cancer research.
- 30 Jun 2026
- Molecular biomedicine
Prolactin-Releasing Hormone Receptor (PRLHR) enhances radiosensitivity and exacerbates DNA damage in glioblastoma post-irradiation by inhibiting Y-box-binding protein-1 (YBX1) nuclear translocation: a novel perspective on precision radiotherapy.
- 29 Jun 2026
- Molecular biomedicine
Gut microbiota and aging: current understanding and future perspectives.
- 25 Jun 2026
- Molecular biomedicine
Prostatic fibroblast reprogramming by Interleukin-30 activates prostate cancer metastasis programs.
- 24 Jun 2026
- Molecular biomedicine
MET-mediated phosphorylation of YANK2 at Y282 inhibits NEDD4L-dependent SUMOylation and degradation, promoting chemoresistance in glioblastoma.
- 24 Jun 2026
- Molecular biomedicine
Death-associated protein kinase 2 (DAPK2) propagates endoplasmic reticulum stress in macrophages to worsen sepsis through HSPA5-IRE1α axis.
- 23 Jun 2026
- Molecular biomedicine
FAQs on Molecular Biomedicine
How many articles did Molecular Biomedicine publish last year? 
Who is the publisher of Molecular Biomedicine?
